Orabi, Hazem, Lauren Howard, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, et al. “Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy: Findings Based on a Multicenter Shared Equal Access Regional Cancer Hospital Registry.” Eur Urol Open Sci 37 (March 2022): 106–12. https://doi.org/10.1016/j.euros.2022.01.003.
Duke Surgery faculty and residents publish more than 500 peer-reviewed research articles each year, including many publications in high impact factor journals.
Search the list of publications below by faculty name or sort by division to learn more about our research endeavors.
Owens, Jake L., Elena Beketova, Sheng Liu, Qi Shen, Jogendra Singh Pawar, Andrew M. Asberry, Jie Yang, et al. “Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation.” Mol Cancer Ther 21, no. 3 (March 1, 2022): 448–59. https://doi.org/10.1158/1535-7163.MCT-21-0103.
Kibel, Adam S., Brant A. Inman, Russell K. Pachynski, Tuyen Vu, Nadeem A. Sheikh, and Daniel P. Petrylak. “Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens.” J Natl Cancer Inst 114, no. 2 (February 7, 2022): 310–13. https://doi.org/10.1093/jnci/djab025.
Kaye, Deborah R., Lauren E. Wilson, Melissa A. Greiner, Lisa P. Spees, Jessica E. Pritchard, Tian Zhang, Craig E. Pollack, et al. “Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinoma.” J Geriatr Oncol, February 3, 2022. https://doi.org/10.1016/j.jgo.2022.01.008.
Moul, Judd W. “The long-running disparity in early detection and treatment of prostate cancer in African American men.” Can J Urol 29, no. 1 (February 2022): 11003–4.